Using a validated model of damaged nerve cells and impaired nerve-signaling pathways, researchers have that demonstrated that ashwagandha supports significant regeneration of the axons and dendrites of nerve cells along with the reconstruction of synapses, the junctions where nerve cells communicate with other cells. This means ashwagandha extract helps to reconstruct entire networks of your nervous system, and has huge implications for any athlete using CBD to manage head injuries or chronic pain.
In the United States, non-FDA approved CBD products are classified as Schedule I drugs under the Controlled Substances Act. This means that production, distribution, and possession of non-FDA approved CBD products is illegal under federal law. In addition, in 2016 the Drug Enforcement Administration added "marijuana extracts" to the list of Schedule I drugs, which it defined as "an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant." Previously, CBD had simply been considered "marijuana", which is a Schedule I drug.